Establishing a new leader in the medtech space

‍

The Challenge:

Alvica Medical wasn’t just launching a product - it was trying to change the conversation around two of the UK’s most pressing health crises: chronic back pain and the lack of effective stroke rehabilitation. The challenge? In a crowded medtech landscape, simply introducing new solutions (reLounge and Rebless) wouldn’t be enough - they needed to build a stage for the conversation first.

‍

The approach:

Rather than pushing a product-first approach, we put the problem in the spotlight. We commissioned national research to expose the true scale of the UK’s back pain crisis - turning a private health struggle into a national issue. In parallel, we positioned Alvica’s co-founders as leading voices in stroke recovery, ensuring they were shaping the debate on the future of rehabilitation.

‍

‍

The Results:

Alvica’s research secured widespread national media coverage in The Daily Mail, The Express, and The New York Post, driving awareness of both the health crisis and the urgent need for better treatment options. This credibility opened doors for high-value product placements - leading to reLounge being featured in the FT’s How to Spend It, a major milestone in positioning it at the intersection of luxury, wellness, and innovation.

‍

‍

The testimonial:

Alvica Medical Co-founder, Carolina Fransen, said: ‍

“Since working with et al., they’ve achieved national coverage for us almost immediately - something other agencies would take months (if ever) to pull off. But beyond that, they apply their entrepreneurial mindset to actually make things happen, going above and beyond to support us in ways we never expected. 

"Their work is this rare combination of PR expertise, marketing strategy, and real entrepreneurial thinking. We’re beyond impressed and would recommend them to anyone looking for serious, tangible results.”

‍